Shareholders area

ONCOMATRYX BIOPHARMA, S.A.

 

General meetings and announcements

 
Notice of the Extraordinary General Meeting on December 2, 2025

Document
Proxy voting card for the extraordinary General Meeting on December 2, 2025

Document
Remote voting card for the extraordinary General Meeting on December 2, 2025

Document
Resolutions of the Extraordinary General Meeting held on 2 December 2025

Documento

Linkedin X-twitter Youtube

This company is capitalized by INNVIERTE, AN INVESTMENT PROGRAM OF CDTI, E.P.E.

Menu
Legal
Contact us
  • Parque Tecnológico de Bizkaia 801B – 2P
  • 48160 Derio. Bizkaia. SPAIN
  • +34 946 087 037
 
If you prefer, you can send us an email to: info@oncomatryx.com